Health Condition 1: N538- Other male sexual dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hypogonadal men with Sexual Dysfunction Age 18-75 years Willing to be a part of the study Serum Testosterone level Serum LH between 1.2 -8 IU/L
Exclusion criteria
Exclusion criteria: Hyperprolactinaemia Diabetes Mellitus Age 75 years Not willing to be a part of the study Baseline Serum Testosterone =300 ng/dL Men with Hypergonadotropic Hypogonadism (FSH >8IU/L, LH >8IU/L) Men with Hypogonadotropic Hypogonadism (FSH CC allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effect of Clomiphene Citrate on Erectile Function in men with sexual dysfunction and IIEF-15 score.Timepoint: At baseline, 4weeks and 8weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Serum Total Testosterone level. To study the effect of Clomiphene Citrate on orgasmic function. To study the effect of Clomiphene Citrate on sexual desire. To study the effect of Clomiphene Citrate on intercourse satisfaction. To study the effect of Clomiphene Citrate on overall satisfaction.Timepoint: At baseline, 4weeks & 8weeks | — |
Countries
India
Contacts
Ruby Hall Clinic